Definitive Contract HT942523C0005

Award Date 2/27/23
Potential Completion Date 7/26/25
Potential Value $1.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84119, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of the Army Medical Command to Technology Holding LLC, a for-profit limited liability company, for a $249,562.98 Small Business Innovation Research (SBIR) Phase I project. The contract is for basic medical research and development to produce a human monoclonal antibody therapeutic against Klebsiella pneumoniae infection. Technology Holding is an experienced government contractor that has received awards from various defense and civilian...
This is a $1,098,063.48 Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint PEO Chemical and Biological Defense, a U.S. Army organization, to Technology Holding LLC, a small, for-profit limited liability company owned by Subcontinent Asian (Asian-Indian) Americans and based in Salt Lake City, Utah. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for advanced research and development in biotechnology, materials science, energy,...
The Defense Health Agency (DHA) awarded a $249,991.63 firm-fixed-price purchase order to Fabrico Technology, Inc., a minority-owned, Asian-Pacific American owned, small business, for research and development under the STTR Phase I program. The contract is for the "Development of Antibody Treatment of MDR ESKAPE Pathogen, P. aeruginosa" and has a performance period extending to November 30, 2024. This contract is a small business set-aside, reflecting Fabrico's status as a qualified...
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Technology Holding LLC, a small, for-profit limited liability company owned by Subcontinent Asian (Asian-Indian) Americans and based in Salt Lake City, Utah. The $249,991.68 contract was awarded under the Small Business Innovation Research (SBIR) Program Phase I, for a project titled "Medical Sterilizer for Far Forward Austere Environments." The contract has a completion date of October 24,...
This is a $1,299,972.00 firm-fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Fabrico Technology, Inc., a minority-owned and Asian-Pacific American-owned small business, under the Small Business Technology Transfer (STTR) Phase II program. The contract is for the "Development of Antibody Treatment of MDR ESKAPE Pathogen, P. Aeruginosa," which involves medical research and development related to chemical and biological defense, antibody treatments, and...
This is a $167,499.12 firm-fixed-price purchase order awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Technology Holding LLC, a for-profit limited liability company, through the Small Business Innovation Research (SBIR) Program Phase I. The contract is set aside for small businesses. Technology Holding LLC is a Subcontinent Asian (Asian-Indian) American-owned company that conducts R&D across areas like biotechnology, materials...
<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>
The Department of the Army Medical Command awarded a Small Business Innovation Research (SBIR) Program Phase I purchase order contract valued at $249,938.69 to Centivax, Inc., a for-profit small business, to develop a human monoclonal antibody therapeutic against Klebsiella pneumoniae infection. This contract is part of the SBIR program, which funds research and development efforts at small businesses. Centivax specializes in developing monoclonal antibody therapeutics against bacterial and...
This is a $149,999 Small Business Technology Transfer (STTR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Technology Holding LLC, a small, for-profit limited liability company. The contract is for the development of &quot;Biomimetic Material Solutions for the Stabilization of Labile Reagents,&quot; which aims to leverage innovative biotechnology and materials science to address national security needs. Technology Holding LLC is the prime contractor on this...
This is a Firm Fixed Price (FFP) contract awarded by the U.S. Army Medical Command (MEDCOM) to Technology Holding LLC, a small business, for a Small Business Innovation Research (SBIR) Phase II project titled &quot;Novel Biologic Countermeasure for Acute Radiation Syndrome.&quot; The contract has a ceiling value of $2,999,993.84 and a period of performance from June 2022 to October 2025. The R&amp;D effort is focused on developing a novel biologic countermeasure to address acute radiation...

The Defense Health Agency (DHA) has awarded a $1,099,025.87 Small Business Technology Transfer (STTR) Phase II contract to Technology Holding LLC, a small, for-profit limited liability company based in Salt Lake City, Utah. The contract is for the "Development of Human Monoclonal Antibody Therapeutic Against Klebsiella Pneumoniae Infection." This research and development effort aims to develop a therapeutic antibody to treat Klebsiella pneumoniae infections. The contract has a completion date of July 26, 2025 and is a firm fixed-price definitive contract. Technology Holding LLC has demonstrated expertise in advanced biotechnology research, including work on human monoclonal antibodies and autonomous biomanufacturing, through prior federal contract awards and grants.

Generated 8/13/25, 10:45 AM